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Abstract
Background: Cancer-cachexia induces a variety of metabolic disorders on protein turnorver,
decreasing protein synthesis and increasing protein degradation. Controversly, insulin, other
hormones, and branched-chain amino acids, especially leucine, stimulate protein synthesis and
modulate the activity of translation initiation factors involved in protein synthesis. Since the tumour
effects are more pronounced when associated with pregnancy, ehancing muscle-wasting
proteolysis, in this study, the influence of a leucine-rich diet on the protein synthesis caused by
cancer were investigated.
Methods: Pregnant rats with or without Walker 256 tumour were distributed into six groups.
During 20 days of experiment, three groups were fed with a control diet: C – pregnant control, W
– tumour-bearing, and P – pair-fed, which received the same amount of food as ingested by the W
group; three other groups of pregnant rats were fed a leucine-rich diet: L – pregnant leucine, WL
– tumour-bearing, and PL – pair-fed, which received the same amount of food as ingested by the
WL group.
Results: The gastrocnemius muscle of WL rats showed increased incorporation of leucine in
protein compared to W rats; the leucine-rich diet also prevented the decrease in plasma insulin
normally seen in W. The expression of translation initiation factors increased when tumour-bearing
rats fed leucine-rich diet, with increase of ~35% for eIF2α and eIF5, ~17% for eIF4E and 20% for
eIF4G; the expression of protein kinase S6K1 and protein kinase C was also highly enhanced.
Conclusion: The results suggest that a leucine-rich diet increased the protein synthesis in skeletal
muscle in tumour-bearing rats possibly through the activation of eIF factors and/or the S6kinase
pathway.
Background
Cancer-cachexia induces a variety of metabolic disorders,
including marked weight loss, especially in adipose and
muscle tissues [1]. Skeletal muscle loss causes alterations
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in protein metabolism that involve a decrease in protein
synthesis and an increase in protein degradation [2,3].
Insulin, other hormones, and nutrients such as branched-
chain amino acids [4], stimulate protein synthesis.
Leucine, a branched-chain amino acid, stimulates muscle
protein synthesis and modules the activity of various pro-
teins involved in the control of mRNA translation [5,6].
Leucine can stimulate protein synthesis directly and/or via
its metabolite, α-ketoisocaproic acid (KIC) [7]. Protein
synthesis is regulated by interactions between mRNA,
tRNA and eukaryotic initiation factors (eIFs). Leucine can
stimulate translation via the mammalian target of
rapamycin (mTOR) or independently [8-10]. In addition,
leucine can stimulate glucose uptake by protein kinase C
(PKC), in contrast to insulin which modulates glucose
uptake via protein kinase B (PKB) [11].
During the early stages of rat pregnancy, protein is synthe-
sized and accumulated in the maternal organism and is
later mobilized during the last days of pregnancy to pro-
vide substrates for the fetus [12]. To some extent, the fetus
can be compared to rapid tumor growth since both tissues
have an exponential growth and are dependent on an ade-
quate supply of glucose and amino acids [13]. For this rea-
son, the association between cancer and pregnancy may
change the nutritional supply to both tumour and fetal
tissues. Our previous results showed that the total body
protein wasting can be enhanced in this situation [13,14]
and prevented by nutritional supplementation with leu-
cine [14]. Knowing this, the aim of this study was to exam-
ine the effects of a leucine-rich diet on the increased
protein degradation and reduced protein synthesis seen in
the skeletal muscle of tumour-bearing pregnant rats.
Methods
Animals and diets
Young female Wistar rats (45 days old, n = 60) were
obtained from the animal facilities of the State University
of Campinas (UNICAMP). The rats were housed over-
night with adult males (4 females: 1 males), using the
harem method [15]. The first day of pregnancy was deter-
mined based on the detection of sperm in the vaginal
smear. All pregnant rats were then housed in collective
cages with free access to water and food under standard
conditions (22 ± 2°C, 12/12-h light/dark cycle). During
20 days, the animals were fed with the semipurified diets
which consisted of a balanced control diet (C, 18% pro-
tein, AIN-G93) and a leucine-rich diet (L, 15% protein
with 3% leucine), both containing the same amount of
carbohydrate (63%), fat (7%) and fibres (5%), in accord-
ance with the AIN-G93 recommendations [16]. Corn
Products Brazil Ingredients supplied some of the diet
components, (corn standard and dextrin), whereas the
vitamin mix was from DSM Nutritional Products Brazil
Ltda., and the amino acids were from Ajinomoto Intera-
mericana Ind. & Com. Ltda., Brazil. The pregnant rats were
randomly distributed into six groups. Three groups were
fed the control diet: C – pregnant control, W – tumour-
bearing, and P – pair-fed, with the latter receiving the
same amount of food as ingested by the W group; three
other pregnant groups were fed the leucine-rich diet: L –
pregnant leucine, WL – tumour-bearing, and PL – pair-
fed, the latter receiving the same amount of food as
ingested by the WL group.
Tumour implantation
The rats assigned to the tumour-bearing groups, W and
WL, received a subcutaneous injection of Walker 256
tumour cells (approx. 0.25 × 106 viable cells in 0.5 mL of
saline solution) in the right flank after the confirmation of
pregnancy. As a standard procedure, the pregnant groups
without tumours (C, L, P and PL) received a single injec-
tion of 0.5 mL of 0.9% NaCl (w/v) in the right flank. All
groups were monitored for 20 days after tumour implan-
tation. The general UKCCCR [17] guidelines for animal
welfare were followed, and the protocols were approved
by the institutional Committee for Ethics in Animal
Research (CEEA/IB/UNICAMP, protocol 217-5).
Experimental procedures
The rats were killed 20 days after tumor implantation and
the gastrocnemius muscles were collected to analyse the
incorporation of leucine into muscle protein, and to
assess the expression of eukaryotic initiation factors, S6K1
and PKC. Plasma samples were collected to measure the
insulin concentration by radioimmunoassay (RIA) [18].
Leucine incorporation was assayed in right gastrocnemius
muscles, which were weighed and placed in Krebs-Hense-
leit bicarbonate (KHB) buffer (composition, in mM: NaCl
110, NaHCO3 25, KCl 3.4, CaCl2 1, MgSO4 1, KH2PO4 1,
glucose 5.5, pH 7.4) supplemented with 1.26 mmol/L
leucine. The muscles were pre-incubated separately for 30
min at 37°C with continuous aeration (95% O2-5% CO2)
and shaking, as described by Vary et al. [19]. After this
period, new KHB buffer supplemented with [3H]-leucine
(10 μCi.L-1; Amersham Biosciences, Little Chalfont, Buck-
inghamshire, UK) was added and the incubation was con-
tinued for a further 2 h. At the end of this period, the
muscles were homogenised in trichloroacetic acid (TCA,
1:3 w/v), centrifuged at 10,000 × g for 15 min at 4°C and
the pellet was suspended in 1 M NaOH and incubated at
40°C for 30 min. Aliquots of this supernatant were used
to measure the total protein [20] and to quantity the radi-
oactivity by liquid scintillation using a β-counter. The
rates of incorporation were calculated based on the
amount of radioactive leucine incorporated in a 2 h
period and expressed as pmols [3H]-Leu per mg of muscle
protein [19].BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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Quantification of eIF2, eIF4E, eIF4G, eIF5, p70 S6K1 and 
PKC in gastrocnemius skeletal muscle
Aliquots of muscle samples were weighed and homoge-
nised in buffer (20 mM N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid, 100 mM KCl, 0.2 mM EDTA, 2 mM
EGTA, 1 mM dithiothreitol, 50 mM NaF, 1 mM 3,3'-
diaminobenzide tetrahydrochloride (DAB), 0.5 mM
orthovanadate, and 50 mM glycine, pH 7.4) followed by
centrifugation at 10,000 × g for 15 min at 4°C. Skeletal
muscle proteins were resolved by SDS-PAGE on 12% gels
followed by transfer of the proteins to a 0.45 μm Hybond-
C nitrocellulose membrane (Amersham). All of the anti-
bodies were purchased from Santa Cruz Technology
(Santa Cruz, CA, USA). The level of eIF2α, eIF4E and
eIF4G expression was assessed using a monoclonal rat
antibody against eIF2α, eIF4E and eIF4G (diluted 1:750)
followed by detection with a secondary anti-goat horse-
radish peroxidase (HRP)-labelled antibody (diluted
1:1000). The expression of eIF5 was assessed using an
anti-rabbit monoclonal eIF5 (1:750) followed by detec-
tion with a secondary anti-rabbit antibody (1:1000).
p70S6 kinase expression was assessed using a specific anti-
mouse monoclonal S6K1 (1:1000) followed by detection
with a secondary anti-mouse antibody (1:1000). Protein
kinase C was detected with an anti-mouse antibody
against PKC (1:1000) and a secondary monoclonal anti-
mouse antibody HRP. Actin (Boehringer Mannheim, Ger-
many) was used as the loading control and was probed
with a mouse anti-actin antibody. All of the blots were
developed using enhanced chemiluminescence (ECL) rea-
gent (Amersham) and the immunoreactive bands were
quantified by densitometry. Images of the gels were cap-
tured (FTI 500 Image Master VDS, Pharmacia Biotech)
and densitometric analyses of the bands were done using
Gel Pro Analyser software (Media Cybernetics, Silver
Spring, MD, USA).
Statistical analysis
The results were expressed as the mean ± SEM. The statis-
tical comparisons were done using one-way ANOVA [21]
followed by Bonferroni's test for comparisons among
groups. All statistical calculations were done using Graph-
Pad Prism software, v3.00 (GraphPad Inc., San Diego, CA,
USA). A value of P < 0.05 indicated significance.
Results
The incorporation of leucine into gastrocnemius muscle
protein is shown in Figure 1. Tumour growth reduced leu-
cine incorporation in the tumour-bearing groups, W and
WL, compared to the respective control groups, C and L.
However, the leucine incorporation in the tumour-bear-
ing group fed the leucine-rich diet (WL) was not signifi-
cantly different from that of the L group. The
incorporation of leucine into muscle protein was ~23%
lower in the tumour-bearing group (W = 12.00 ± 2.17
pmol [3H]-Leu/mg/h) compared to the WL group (15.61
± 1.21 pmol [3H]-Leu/mg/h). The pair-fed groups, P and
PL, showed no significant difference compared to the C
and L groups (Figure 1). Recent studies have shown that
skeletal muscle protein synthesis is stimulated by
branched-chain amino acids, especially leucine, adminis-
tered orally or in perfused muscle [22-24].
Leucine and other branched-chain amino acids stimulate
insulin synthesis and release in rats [25]. Tumour growth
markedly decreased the plasma insulin concentration in
the group W compared to groups C and P (C = 6.013 ±
1.000 ng.mL-1; W = 0.785 ± 0.077 ng.mL-1*; P = 3.500 ±
0.408 ng.mL-1;*p < 0.05 compared to C and P).This find-
ing agreed with other studies in Walker tumour-bearing
rats that reported a reduction in the plasma insulin level
caused by a decrease in insulin synthesis and release by
the β-cells of pancreatic islets [26,27]. The leucine-rich
diet prevented the decrease in plasma insulin level associ-
ated with tumour growth in the WL group (L = 6.216 ±
0.872 ng.mL-1; WL = 3.547 ± 0.286*; PL = 5.019 ± 0.552;
*p < 0.05 compared to C and P). In addition, the decrease
in plasma insulin concentration in the WL group (~1.7-
fold)was significantly less than in the W group (~7.6-
fold).
Protein synthesis is a complex process that involves a
number of protein factors and ribosomal structures. The
initiation of protein synthesis requires eIF2 activity that
induces the GTP-dependent binding of Met-tRNAi to the
40S ribosomal subunit to form a preinitiation complex
[3,28]. The expression of eIF2α (Figure 2A) increased in
the groups fed a leucine-rich diet. The increase in eIF2α
expression was ~22% in the L group, but was not signifi-
cantly different from the control group C. In groups WL
(0.194 ± 0.012 arbitrary densitometric units) and PL
(0.195 ± 0.007 arbitrary densitometric units), the elF2α
expression increased by ~35% and ~27% compared to
groups W (0.126 ± 0.012) and P (0.142 ± 0.003), respec-
tively. Factor eIF5 catalyses the binding of GTP to eIF2 fac-
tor in the preinitiation complex [29]. In our experiments,
eIF5 expression was higher in WL than in W rats (0.1685
± 0.0052 vs. 0.1054 ± 0.0056 arbitrary densitometric
units; p < 0.001) (Figure 2B).
The activity of the eIF4F complex, which involves the
assembly of three initiation factors, including eIF4E and
eIF4G, is necessary for recognition and binding of the 43S
complex to the 5' terminal of mRNA and for optimal
translation [29,30]. Expression of the subunit eIF4E,
which recognises the 5' terminal m7GTP cap structure at
the 5' end of eukaryotic mRNA [30], was significantly
reduced in W rats compared to the other groups, espe-
cially WL rats (Figure 3A; C = 0.0516 ± 0.0009, W =
0.0429 ± 0.0014*, P = 0.0468 ± 0.0023, L= 0.0485 ±BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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0.0008, WL = 0.0519 ± 0.0013 and PL = 0.0528 ± 0.0014
arbitrary densitometric units; *p < 0.01 compared to
groups C, WL and PL). Similarly, eIF4G, the subunit that
binds to the 43S preinitiation complex, was less expressed
in tumour-bearing rats (W = 0.0987 ± 0.0014 arbitrary
densitometric units) compared to the other groups (C =
0.1222 ± 0.0093, P = 0.1040 ± 0.0045, L = 0.1329 ±
0.0066 and PL= 0.1101 ± 0.0037 arbitrary densitometric
units), while the leucine-rich diet significantly increased
eIF4G expression by ~20% in the WL group compared to
W (0.1253 ± 0.0024 vs. 0.0987 ± 0.0014 arbitrary densit-
ometric units, p < 0.05) (Figure 3B).
The oral administration of leucine increases the phospho-
rylation of S6K1 in rat muscles [31]. There was a reduction
in S6K1 expression in the gastrocnemius muscle of W rats
compared to C rats (0.182 ± 0.005 vs. 0.473 ± 0.007 arbi-
trary densitometric units) (Figure 4A (WB image) and 4B).
Although the expression of S6K1 in WL rats was lower
than in L rats (0.362 ± 0.005 vs. 0.470 ± 0.005 arbitrary
densitometric units), the expression of this kinase was
~32% higher in WL rat muscle than in W rats (p < 0.001).
PKC expression was significantly higher (p < 0.001) in all
groups fed the leucine-rich diet (L = 0.156 ± 0.018, WL =
0.161 ± 0.012, PL = 0.154 ± 0.011 arbitrary densitometric
units) compared to those fed the control diet (C = 0.086
± 0.003, W = 0.071 ± 0.002 and P = 0.102 ± 0.003 arbi-
trary densitometric units). However, there was no signifi-
cant difference between the WL and L (control) groups
(0.161 ± 0.011 vs. 0.156 ± 0.018 arbitrary densitometric
units) (Figure 4A (WB image) and 4C), although this
parameter was 2.27-fold higher in WL than in W rats.
Effects of a leucine-rich diet on leucine incorporation into protein in gastrocnemius skeletal muscle from pregnant, tumour- bearing rats Figure 1
Effects of a leucine-rich diet on leucine incorporation into protein in gastrocnemius skeletal muscle from pregnant, tumour-
bearing rats. Right gastrocnemius muscles from all experimental groups were incubated with [3H]-L-Leucine for 2 h. For 
details, see Methods. At least 10 rats were used per group. Abbreviations: C, control; W, tumour-bearing rats; P, pair-fed 
tumour-bearing rats; L, leucine-rich diet group; WL, tumour-bearing rats fed a leucine-rich diet; PL, pair-fed tumour-bearing 
group fed a leucine-rich diet. The columns are means ± SEM. * P < 0.05 estatistically different compared to all groups.BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour- bearing rats Figure 2
Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour-
bearing rats. Western blot images and arbitrary densitometric values for the expression of eIF2α (A) and eIF5 (B). Aliquots of 
gastrocnemius muscle homogenates were loaded onto SDS-PAGE gels (5 μg protein/well) and, after electrophoresis, the pro-
teins were transferred to nylon membranes and blotted with antibodies to eIF2α and eIF5 (1:750 dilution). For details, see 
Methods. Abbreviations are defined in the legend to Figure 1. The columns are the means ± S.E.M. of at least 10 rats per group. 
There was no variation in the expression of actin (42 kDa). * P < 0.05, for comparison WL vs W and PL vs P.BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour- bearing rats Figure 3
Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour-
bearing rats. Western blot images and arbitrary densitometric values for the expression of eIF4E (A) and eIF4G (B). Aliquots of 
gastrocnemius muscle homogenates were loaded onto SDS-PAGE gels (5 μg protein/well) and, after electrophoresis, the pro-
teins were transferred to nylon membranes and blotted with antibodies to eIF4G and eIF4E (1:750 dilution). For details, see 
Methods. Abbreviations are defined in the legend to Figure 1. The columns are the means ± S.E.M. of at least 10 rats per group. 
There was no variation in the expression of actin (42 kDa). * P < 0.05 for comparison with all groups.BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour- bearing rats Figure 4
Effects of a leucine-rich diet on the expression of initiation factors in gastrocnemius skeletal muscle from pregnant, tumour-
bearing rats. (A) Western blot images of S6K1 (70 kDa), PKC (80 kDa) and actin (42 kDa). These images are representative of 
the best assay from each group (minimum of 10 rats per group). (B) Arbitrary densitometric values for S6K1 expression from 
western blots of eight rats per group. (C) Arbitrary densitometric values for PKC expression from western blots of eight rats 
per group. Aliquots of gastrocnemius muscle homogenates were loaded onto SDS-PAGE gels (5 μg protein/well) and, after 
electrophoresis, the proteins were transferred to nylon membranes and blotted with antibodies to eIF2α and eIF5 (1:1500 
dilution). For details, see Methods. Abbreviations are defined in the legend to Figure 1. The columns are the means ± S.E.M. of 
at least 8 rats per group. There was no variation in the expression of actin (42 kDa). * P < 0.05 for comparison W vs C and 
WL, PL vs P; ** P < 0.05 for comparison WL vs L; † P < 0.05 for comparison L vs C, WL vs W, PL vs P.BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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Discussion
Cachexia, a severe condition in cancer patients, involves
wasting of the body tissues with a loss of muscle mass that
may reduce performance, the response to chemotherapy,
and life expectancy. Since the depletion of lean body mass
in cancer cachexia is the major factor in decreasing the sur-
vival time, an improvement in protein synthesis and/or a
reduction in protein catabolism could interfere with phys-
iological processes involved in patient welfare. As shown
here, a leucine-rich diet improved the protein metabolism
of muscle tissue by enhancing the expression of eukaryo-
tic initiation factors that is normally depressed during
tumour growth. Since protein synthesis is reduced and
protein degradation is increased throughout the body
during cancer cachexia, the incorporation of amino acids,
especially branched-chain amino acids, by muscle cells
could supply important nutrients and influence protein
synthesis. The lower incorporation of leucine into gastroc-
nemius muscle proteins in tumour-bearing rats indicated
a decrease in protein synthesis that paralleled an increase
in protein wasting, as previously reported by ourselves
[1,2,32] and others [33,34]. As shown here, the leucine-
rich diet reduced the protein catabolism and increased the
protein synthesis in WL rats compared to W rats.
The rate of protein synthesis depends on the nutritional
and physiological status of the animal [35-37], including
the availability of dietary protein and amino acids [8,38],
although in the pair-fed groups studied here (P and PL)
there was no reduction in leucine incorporation into mus-
cle protein compared to the tumour-bearing groups. In
animals and human pregnancy [12-14,36,37] the protein
synthesis is highly activated, especially during the early
stages of pregnancy. The findings in pair-fed groups sug-
gested that food restriction caused less wasting of muscle
protein than did tumour growth. Even at the late stage of
pregnancy in rat, there is protein synthesis associated to
high proteolysis [12-14,36,37], providing substracts to
fetus and also to tumor cells [14]. This fact suggests that
the rapid tumor growth-induced hypercatabolism in preg-
nant rats shows more evident effects on protein turnover.
In recent years, the impact of nutrients on cell signalling
events and the regulation of protein synthesis by
branched-chain amino acids have become an important
area of research [39]. Protein synthesis involves many
eukaryotic initiation factors (eIFs) that are involved in a
complex, multistage process regulated by three steps
[29,40]. The first step involves association of the 40S
ribosomal subunit with eIF2 and GTP to form a ternary
complex (eIF2-GTP-Met-tRNA), with eIF2α being a key
target in translational regulation [41]. The reduction in
skeletal muscle protein synthesis seen during cancer
cachexia (W group, previously observed in our study [2])
was associated with a decrease in eIF2α and eIF5 expres-
sion and a reduction in leucine incorporation, indicating
the ability of tumour growth to produce important tissue
wasting. On the other hand, eIF2α expression was
strongly enhanced in the leucine-treated groups (L, PL and
especially LW) and was correlated with increased eIF5
expression and the maintenance of leucine incorporation.
Since eIF5 is a catalytic factor for many translation factors,
including the release of eIF2-GDP from met-tRNA, then
once the eIF2-GDP complex is released it may participate
in another round of initiation, with GDP being exchanged
for GTP prior to the formation of a new eIF2-GTP-met-t
RNA complex.
The second step in the initiation of translation involves
the binding of mRNA to the 40S ribosomal subunit, an
interaction that is mediated by a triad of initiation factors
including eIF4E, which associates with eIF4G to form an
active complex (eIF4F) [29,35,39,40]. The decreased
eIF4E expression seen in tumour-bearing rats suggested
that there was less translation and, consequently, less pro-
tein synthesis since eIF4E is necessary for assembly of the
eIF4G-eIF4E complex which modulates the overall rate of
protein synthesis. The enhanced formation of eIF4F may
involve the phosphorylation of eIF4G, which is correlated
with the stimulation of protein synthesis [42]. Similarly,
decreased eIF4G-eIF4E assembly and a corresponding
decrease in eIF4G phosphorylation in the presence of
mTOR activation has been observed in the skeletal muscle
of septic rats [43,44].
The leucine-dependent stimulation of mRNA translation
is partly insensitive to rapamycin [45]. This finding is sup-
ported by the observation that skeletal muscle protein
synthesis and eIF4E-eIF4G assembly are enhanced by the
administration of leucine in the presence of rapamycin (a
specific inhibitor of mTOR) [45]. Additionally, oral leu-
cine administration enhanced the phosphorylation of 4E-
BP1, showing the stimulation effect of leucine on protein
synthesis in skeletal muscle of normal rats [46]. Con-
versely, leucine alone has beneficial effects on skeletal
muscle metabolism in tumour-bearing animals [2]. As
shown here, leucine tended to increase the expression of
eIF4G in skeletal muscle. This slight increase in the
amount of eIF4G could result in greater binding to eIF4E.
The regulation of the initiation of translation depends on
the availability of eIF4E [35], the levels of which were
maintained in the leucine-rich diet group (LW). The oral
administration of isoleucine, which is less effective than
leucine, activates the initiation of translation in skeletal
muscle in rats [23], and the binding of eIF4G to eIF4E is
enhanced by isoleucine and leucine in rats [27,31,47].
Another mechanism for regulating protein synthesis is the
phosphorylation of the ribosomal protein S6 that is medi-
ated by the 70 kDa ribosomal protein S6 kinase (S6K1)BMC Cancer 2007, 7:42 http://www.biomedcentral.com/1471-2407/7/42
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[48]. The activation of S6K1 increases the capacity to syn-
thesise protein [39,45].
The cellular mechanisms by which amino acids modulate
protein synthesis are now beginning to be understood.
Amino acids, and leucine in particular, consistently acti-
vate S6K1 and promote translation [49]. Among
branched-chain amino acids, leucine apparently has the
greatest effect in activating S6K1 [50,51]. Since increased
S6K1 activity has been associated with increased protein
synthesis and enhanced translation of mRNA [52], our
results suggest that the leucine pathways in muscle pro-
tein synthesis require an increased availability of eIF4E,
and S6K1 activity. The availability of leucine could acti-
vate S6K1, as verified by Yoshizawa and collegues [46,53]
thereby enhancing the protein synthesis in gastrocnemius
muscle, as seen in the WL, L and PL groups. Although
Yoshizawa and collegues [46,53] observed increase on
translational factos activity after 1 hour leucine feeding,
the authors found that this stimule reduced to basal level
after 3 h. Controvertly, in the present study, probably the
increased on eIF4E, and S6K1 were directely related to the
constant stimule by the leucine-rich diet intake, during 20
days. This activation could be mediated by mTOR through
different mechanisms [54].
Several reports have suggested a possible interplay
between leucine, mitochondrial function and mTOR sig-
nalling [55,56]. Xu et al. [57] proposed that leucine stim-
ulates S6K1 phosphorylation via the mTOR pathway,
partly by serving as a mitochondrial fuel through oxida-
tive carboxylation and partly by mediating the allosteric
activation of glutamate dehydrogenase, thereby decreas-
ing the activity of AMP-activated protein kinase (AMPK).
Leucine enhances glucose uptake by the PKC-dependent
pathway [4,11], and the increased PKC expression in all of
the groups fed a leucine-rich diet suggested that leucine
improved the glucose uptake and minimised the effects of
cancer-cachexia in skeletal muscle (WL).
When amino acids and glucose are present in adequate
amounts, AMPK, which usually inhibits the mTOR-S6K1
pathway, is depressed and there is an increase in protein
synthesis [55]. Although cancer-cachexia decreases
plasma insulin levels [58,59], the leucine-rich diet
improved the plasma insulin level in the LW group, and
could serve as a stimulus for protein synthesis [60]. The
oral administration of leucine in vivo results in transient
increases in circulating insulin, but blocking this response
with somatostatin prevents the leucine-induced hyper-
phosphorylation of 4E-BP1 and S6K1 in rat skeletal mus-
cle, whereas formation of the eIF4E-eIF4G complex is
increased [25,31]. However, amino acids do not stimulate
phosphatidylinositol 3-kinase(PI3-K) or protein kinase B
(PKB) (Akt) signalling pathways activated by insulin and
growth factors [50,61,62]. Bolster and colleagues [63]
reported that leucine had no effect on 4E-BP1 and S6K1
during skeletal muscle protein synthesis, in contrast to the
findings of studies in vivo [23] and in vitro [64] which
suggested that the residual insulin signalling seen in
postabsorptive state rats provided the basal phosphoryla-
tion for 4E-BP1 and S6K1; however, this level of signalling
was insufficient to cause hyperphosphorylation, regard-
less of the availability of leucine.
Although the combined effect of leucine and insulin pro-
vides an integrated response, leucine alone may preferen-
tially enhance the expression and activity of selected
components of translation initiation, thereby increasing
protein synthesis. As shown here and elsewhere [2], a leu-
cine-rich diet increased protein synthesis in skeletal mus-
cle of tumour-bearing rats and thereby enhanced the
levels of many signalling factors. The finding that leucine
influenced the synthesis of eIF factors and/or activated the
S6kinase pathways could lead to new alternatives for com-
plimentary treatment during cancer therapy. Specifically,
we are currently investigating whether leucine supple-
mentation can counteract body weight loss during cancer
cachexia by inducing protein synthesis.
Conclusion
The oral administration of leucine-rich diet induced the
increase on the protein synthesis in skeletal muscle in
tumour-bearing rats possibly through the activation of eIF
factors and/or the S6kinase pathway.
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